Clinical Trial Update: Viral Specific T Cell Therapy for COVID-19 Related Pneumonia [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial of viral-specific T cell therapy for COVID-19-related pneumonia has completed, evaluating safety and feasibility in patients with prior h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Malignant Solid Tumor

Drugs mentioned

• Viral-specific T cell therapy

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | EARLY_Phase 1 | Status: COMPLETED